MGNX · Macrogenics Inc

$4.54 +0.22 (+5.09%) At close · Jul 21

Market Cap

$273.32M

63.56M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Risser	CEO	$561,568	$150,000	$52,000	$1,049,386	$251,900	$14,000	$2,078,854
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$533,200	$150,000	$54,600	$288,038	$184,200	$14,000	$1,224,038
James Karrels	CFO	$506,548	$150,000	$49,400	$254,284	$175,000	$14,000	$1,149,232
Scott Koenig	CEO	$477,120	—	—	—	—	$475,841	$952,961

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$734,031	—	$1,738,500	$3,574,647	$342,470	$13,800	$6,403,448
Stephen Eck	Senior Vice President of Clinical Development and Chief Medical Officer	$542,769	—	$613,050	$1,297,251	$178,739	$13,800	$2,645,609
James Karrels	CFO	$491,077	—	$549,000	$1,153,112	$158,554	$13,800	$2,365,543

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$704,914	—	$612,140	$1,894,191	$481,380	$13,200	$3,705,825
Stephen Eck	Senior Vice President of Clinical Development and Chief Medical Officer	$521,808	—	$241,000	$742,820	$231,840	$13,200	$1,750,668
James Karrels	CFO	$471,106	—	$216,900	$668,538	$209,000	$13,200	$1,578,744

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$673,420	—	—	$3,568,656	$373,672	$12,200	$4,627,948
Eric Risser	COO	$460,802	—	—	$1,263,899	$178,360	$12,200	$1,915,261
James Karrels	CFO	$447,346	—	—	$1,040,858	$167,283	$12,200	$1,667,687

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$651,119	—	—	$3,914,372	$294,323	$8,700	$4,868,514
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$462,328	—	—	$1,677,588	$141,180	$8,700	$2,289,796
James Karrels	CFO	$431,908	—	—	$1,328,091	$137,295	$8,700	$1,905,994
Eric Risser	COO	$427,957	—	—	$1,328,091	$135,327	$8,700	$1,900,075
Thomas Spitznagel	Senior Vice President, Technical Operations	$409,972	—	—	$1,328,091	$132,302	$8,700	$1,879,065

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Eck	Senior Vice President of Clinical Development and Chief Medical Officer	$236,308	—	—	$4,788,880	$97,920	$7,089	$5,130,197
Scott Koenig	CEO	$655,865	—	—	$2,065,873	$381,000	$8,550	$3,111,288
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$465,699	—	$249,700	$712,370	$183,960	$8,550	$1,620,279
James Karrels	CFO	$431,496	—	—	$641,133	$173,791	$8,550	$1,254,970
Eric Risser	COO	$431,077	—	—	$641,133	$170,284	$8,550	$1,251,044

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$590,019	—	—	$3,818,152	$307,017	$8,400	$4,723,588
Jon Wigginton	Chief Medical Officer	$453,454	—	—	$1,321,668	$163,366	$3,763	$1,942,251
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$418,952	—	—	$1,321,668	$147,784	$8,400	$1,896,804
James Karrels	CFO	$387,600	—	—	$1,248,242	$137,255	$8,400	$1,781,497
Eric Risser	COO	$387,806	—	—	$1,248,242	$135,177	$8,400	$1,779,625

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$598,500	—	—	$4,289,558	$309,425	$8,250	$5,205,733
Jon Wigginton	Chief Medical Officer	$460,000	—	—	$1,334,529	$173,328	$8,250	$1,976,107
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$425,000	—	—	$1,334,529	$160,140	$8,250	$1,927,919
Eric Risser	President, Chief Executive Officer and Director	$393,404	—	—	$1,334,529	$148,549	$8,250	$1,884,732
James Karrels	CFO	$390,000	—	—	$1,334,529	$148,512	$8,250	$1,881,291

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	CEO	$554,346	—	—	$2,565,060	$350,624	$8,100	$3,478,130
Jon Wigginton	Chief Medical Officer	$445,050	—	—	$865,708	$197,600	$8,100	$1,516,458
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$404,685	—	—	$865,708	$179,700	$8,100	$1,458,193
Eric Risser	President, Chief Executive Officer and Director	$374,670	—	—	$705,392	$176,800	$8,100	$1,264,962
James Karrels	CFO	$360,000	—	—	$705,392	$160,700	$8,100	$1,234,192

Executive changes

Person	Role	Change	Effective	Filed
Karen Ferrante, M.D.	board of directors	Resigned	2026-09-01	2026-07-08

Key facts CIK 1125345 CUSIP 556099109 13F (30d) 6 filings 6 filers Visit website Investor relations